三友医疗(688085)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688085 三友医疗

已收盘 03-24 15:00:00

{"stockData":{"symbol":"688085","market":"SH","secType":"STK","nameCN":"三友医疗","latestPrice":18.36,"timestamp":1774335600000,"preClose":17.59,"halted":0,"volume":2493079,"delay":0,"changeRate":0.0438,"floatShares":319000000,"shares":333000000,"eps":0.1946,"marketStatus":"已收盘","change":0.77,"latestTime":"03-24 15:00:00","open":17.8,"high":18.49,"low":17.7,"amount":45178900,"amplitude":0.0449,"askPrice":18.36,"askSize":60,"bidPrice":18.34,"bidSize":4,"shortable":0,"etf":0,"ttmEps":0.1946,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774402200000},"marketStatusCode":5,"adr":0,"adjPreClose":17.59,"symbolType":"stock_kcb","openAndCloseTimeList":[[1774315800000,1774323000000],[1774328400000,1774335600000]],"highLimit":19.35,"lowLimit":15.83,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":333462498,"isCdr":false,"pbRate":2.95,"roa":"--","peRate":94.347379,"roe":"3.08%","epsLYR":0.05,"committee":-0.488114,"marketValue":6122000000,"turnoverRate":0.0078,"status":0,"afterMarket":{"amount":62424,"volume":3400,"close":18.36,"buyVolume":2200,"sellVolume":0,"time":1774337637558,"indexStatus":"已收盘 03-24 15:30:00","preClose":17.59},"floatMarketCap":5852000000},"requestUrl":"/m/hq/s/688085","defaultTab":"news","newsList":[{"id":"2621799674","title":"每周股票复盘：三友医疗（688085）现12笔大宗交易 机构净买入1416.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621799674","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621799674?lang=zh_cn&edition=full","pubTime":"2026-03-22 02:50","pubTimestamp":1774119019,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，三友医疗报收于18.65元，较上周的20.49元下跌8.98%。交易信息汇总3月18日三友医疗现12笔大宗交易，机构净买入1416.8万元。混沌天成18号于2026年2月4日至3月11日通过大宗交易减持2,212,155股，占总股本0.66%，减持完成后持股为0股。Michael Mingyan Liu（刘明岩）于2026年2月4日至3月18日通过大宗交易减持4,457,094股，占总股本1.34%，当前持股比例降至7.76%。本次合计减持6,669,249股，占总股本2.00%，减持计划已全部实施完毕，未违反相关法规及承诺。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000740.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688085"],"gpt_icon":0},{"id":"2620923963","title":"3月18日三友医疗现12笔大宗交易 机构净买入1416.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620923963","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620923963?lang=zh_cn&edition=full","pubTime":"2026-03-18 17:20","pubTimestamp":1773825648,"startTime":"0","endTime":"0","summary":"证券之星消息，3月18日三友医疗发生大宗交易，交易数据如下：近三个月该股共发生21笔大宗交易，合计成交6.67万手，折价成交21笔。该股在过去半年内已有共计495.77万股限售解禁股上市，占公司总股本的1.49%。截至2026年3月18日收盘，三友医疗报收于20.2元，上涨0.5%，换手率0.52%，成交量1.66万手，成交额3349.89万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800029947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688085"],"gpt_icon":0},{"id":"2618543948","title":"3月11日三友医疗现921.87万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2618543948","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618543948?lang=zh_cn&edition=full","pubTime":"2026-03-11 17:21","pubTimestamp":1773220904,"startTime":"0","endTime":"0","summary":"证券之星消息，3月11日三友医疗发生大宗交易，交易数据如下：近三个月该股共发生9笔大宗交易，合计成交4.82万手，折价成交9笔。该股在过去半年内已有共计2059.72万股限售解禁股上市，占公司总股本的6.18%。截至2026年3月11日收盘，三友医疗报收于21.08元，下跌0.94%，换手率1.16%，成交量3.7万手，成交额7875.54万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100028829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688085","BK0251"],"gpt_icon":0},{"id":"2617517287","title":"3月5日三友医疗现1笔折价14.16%的大宗交易 合计成交3888.97万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617517287","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617517287?lang=zh_cn&edition=full","pubTime":"2026-03-05 17:21","pubTimestamp":1772702476,"startTime":"0","endTime":"0","summary":"证券之星消息，3月5日三友医疗发生大宗交易，交易数据如下：大宗交易成交价格17.58元，相对当日收盘价折价14.16%，成交221.22万股，成交金额3888.97万元，买方营业部为兴业证券股份有限公司上海金陵东路证券营业部，卖方营业部为华泰证券股份有限公司北京雍和宫证券营业部。近三个月该股共发生6笔大宗交易，合计成交4.35万手，折价成交6笔。截至2026年3月5日收盘，三友医疗报收于20.48元，上涨1.89%，换手率1.16%，成交量3.69万手，成交额7623.39万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500027975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688085","BK0251"],"gpt_icon":0},{"id":"2616539852","title":"三友医疗最新公告：控股公司Implanet3D打印腰椎椎间融合系统获美国FDA510(K)认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2616539852","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616539852?lang=zh_cn&edition=full","pubTime":"2026-03-04 18:20","pubTimestamp":1772619647,"startTime":"0","endTime":"0","summary":"三友医疗(688085.SH)公告称，公司控股公司法国Implanet的SWINGO-3D Lumbar Cage System（3D打印腰椎椎间融合系统）获得美国FDA 510(K)认证。该系统以三友医疗自主研发的3D打印“金属增材制造椎间融合器”为基础开发，适用于患有退行性椎间盘疾病的骨骼成熟的患者。此次认证标志着三友医疗的海外技术输出战略持续落实，进一步丰富了公司的国际产品线和品牌。然而，实际销售情况受境外市场及客户等多种因素影响，产品销售及利润贡献具有不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400033830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688085","BK0251"],"gpt_icon":0},{"id":"2616238143","title":"3月2日三友医疗跌5.99%，融通健康产业灵活配置混合A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2616238143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616238143?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:31","pubTimestamp":1772440273,"startTime":"0","endTime":"0","summary":"证券之星消息，3月2日三友医疗跌5.99%，收盘报21.82元，换手率2.73%，成交量8.7万手，成交额1.93亿元。重仓三友医疗的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级1家，增持评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共6家，其中持有数量最多的公募基金为融通基金的融通健康产业灵活配置混合A/B。该公募基金现任基金经理为万民远。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200022697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688085"],"gpt_icon":0},{"id":"2616784318","title":"每周股票复盘：三友医疗（688085）净利增451.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616784318","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616784318?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:04","pubTimestamp":1772301852,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，三友医疗报收于23.21元，较上周的22.25元上涨4.31%。本周关注点来自业绩披露要点：三友医疗2025年归属净利润同比增长451.85%。公司公告汇总上海三友医疗2025年度营业总收入为54,279.25万元，同比增长19.66%；归属于母公司所有者的净利润为6,328.95万元，同比增长451.85%；扣除非经常性损益后净利润实现扭亏为盈。公司终端销售扩展与渠道下沉推动骨科业务增长，水木天蓬合并收入增长38.85%，超声骨刀业务快速增长，国际化业务收入同比增长32.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688085"],"gpt_icon":0},{"id":"2614042926","title":"三友医疗(688085.SH)2025年度归母净利润6328.95万元，增加451.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614042926","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614042926?lang=zh_cn&edition=full","pubTime":"2026-02-26 21:28","pubTimestamp":1772112493,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三友医疗(688085.SH)披露2025年度业绩快报，公司实现营业总收入5.43亿元，同比增长19.66%;研发费用8371.08万元，研发投入占比15.42%;实现归属于母公司所有者的净利润6328.95万元，同比增加451.85%;实现归属于母公司所有者的扣除非经常性损益的净利润4966.71万元，与上年同期相比，实现扭亏为盈。2025年，超声骨刀业务在销售业绩和净利润上均取得了快速的增长。公司国际化业务亦保持持续快速发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407824.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"三友医疗(688085.SH)2025年度归母净利润6328.95万元，增加451.85%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688085"],"gpt_icon":0},{"id":"2614011982","title":"三友医疗发布2025年度业绩快报，盈利0.633亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614011982","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614011982?lang=zh_cn&edition=full","pubTime":"2026-02-26 17:50","pubTimestamp":1772099450,"startTime":"0","endTime":"0","summary":"证券之星消息，三友医疗近日即将发布2025年年报，根据2月26日发布的业绩快报，归属净利润盈利0.633亿元，同比增长451.85%。截止报告期末， 公司总资产为 237,682.69 万元，较期初增加 3.04%；归属于母公司的所有者权 益 210,488.68 万元，较期初增加 10.10%。2025 年，超声骨 刀业务在销售业绩和净利润上均取得了快速的增长。报告期内，因公司推出股权激励计划，确认股份支付费用约为 840.00 万元，同时公司计提资产减值损失和信用减值损失等约 3,400.00 万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600029382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688085","BK0251"],"gpt_icon":0},{"id":"1187883004","title":"IMPLANET财年运营收入报亏422万欧元","url":"https://stock-news.laohu8.com/highlight/detail?id=1187883004","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187883004?lang=zh_cn&edition=full","pubTime":"2026-02-25 00:59","pubTimestamp":1771952368,"startTime":"0","endTime":"0","summary":"IMPLANET公布的财年财务数据显示，其净亏损达到438万欧元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688085","BK0251"],"gpt_icon":0},{"id":"2611134852","title":"2月13日三友医疗涨5.25%，融通健康产业灵活配置混合A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2611134852","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611134852?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:33","pubTimestamp":1770971623,"startTime":"0","endTime":"0","summary":"证券之星消息，2月13日三友医疗涨5.25%，收盘报22.25元，换手率3.62%，成交量11.35万手，成交额2.52亿元。重仓三友医疗的公募基金请见下表：该股最近90天内共有4家机构给出评级，买入评级3家，增持评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共6家，其中持有数量最多的公募基金为融通基金的融通健康产业灵活配置混合A/B。该公募基金现任基金经理为万民远。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021300025691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688085"],"gpt_icon":0},{"id":"2611131078","title":"三友医疗涨5.25%，中银证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2611131078","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611131078?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:33","pubTimestamp":1770971615,"startTime":"0","endTime":"0","summary":"今日三友医疗涨5.25%，收盘报22.25元。2025年11月19日，中银证券研究员刘恩阳发布了对三友医疗的研报《国际化表现亮眼，国内业务逐步恢复》，该研报对三友医疗给出“买入”评级。研报中预计公司25-27年归母净利润为1.15/1.79/2.59亿元亿元，对应EPS分别为0.34/0.54/0.78元，当前股价对应PE分别为55.7/35.7/24.7x，考虑到公司超声骨刀业务处于快速放量阶段，国际化业务也已开始逐步突破，我们看好公司未来的发展前景，维持买入评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021300025688.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688085","601696"],"gpt_icon":0},{"id":"2610937678","title":"三友医疗(688085.SH)拟2000万元增资入股椎元医学","url":"https://stock-news.laohu8.com/highlight/detail?id=2610937678","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610937678?lang=zh_cn&edition=full","pubTime":"2026-02-11 20:43","pubTimestamp":1770813832,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三友医疗(688085.SH)发布公告，公司拟使用自有资金2000万元向椎元医学技术(上海)有限公司(简称“椎元医学”)进行增资，交易完成后公司将持有椎元医学9.0909%的股权。近年来，公司在骨科相关领域正不断加强研发和战略布局，拓展临床解决方案的实现边界，共同推动骨科临床手术治疗方案的革新与创新。目标公司核心团队拥有较为深厚的技术积淀与原创性研发，产品具有创新与技术突破。本次对外投资的目的是为了拓展公司业务，目标公司的在研产品线和公司现有业务领域有相当的协同性，有助于进一步提升公司的综合竞争力和影响力，提升公司价值，实现投资者利益最大化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404337.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688085","BK0251"],"gpt_icon":0},{"id":"2609852375","title":"每周股票复盘：三友医疗（688085）现两笔大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2609852375","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609852375?lang=zh_cn&edition=full","pubTime":"2026-02-08 01:29","pubTimestamp":1770485349,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，三友医疗报收于21.93元，较上周的21.88元上涨0.23%。本周，三友医疗2月6日盘中最高价报22.57元。公司公告汇总：三友医疗部分限售股将于2026年2月24日上市流通，数量为495.77万股。交易信息汇总2月4日三友医疗发生2笔大宗交易，合计成交金额3820.84万元，成交价格较当日收盘价折价17.43%。上海三友医疗实际控制人Michael Mingyan Liu于2026年2月4日通过大宗交易减持公司股份2,140,000股，占公司总股本的0.64%。其中Michael Mingyan Liu个人持股比例由9.10%降至8.46%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800000258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688085","BK0251"],"gpt_icon":0},{"id":"2608235286","title":"2月4日三友医疗现2笔折价17.43%的大宗交易 合计成交3820.84万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608235286","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608235286?lang=zh_cn&edition=full","pubTime":"2026-02-04 17:34","pubTimestamp":1770197685,"startTime":"0","endTime":"0","summary":"证券之星消息，2月4日三友医疗发生大宗交易，交易数据如下：近三个月该股共发生8笔大宗交易，合计成交6.67万手，折价成交8笔。该股在过去半年内已有共计1563.95万股限售解禁股上市，占公司总股本的4.69%。截至2026年2月4日收盘，三友医疗报收于21.05元，下跌3.08%，换手率1.27%，成交量3.98万手，成交额8413.93万元。该股近半年内有股东持股变动，合计净减持214.0万股，股东增减持明细如下表：该股最近90天内共有3家机构给出评级，买入评级3家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400029984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688085","BK0251"],"gpt_icon":0},{"id":"2607704330","title":"三友医疗涨5.12%，中银证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2607704330","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607704330?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:37","pubTimestamp":1769675851,"startTime":"0","endTime":"0","summary":"今日三友医疗涨5.12%，收盘报22.6元。2025年11月19日，中银证券研究员刘恩阳发布了对三友医疗的研报《国际化表现亮眼，国内业务逐步恢复》，该研报对三友医疗给出“买入”评级。研报中预计公司25-27年归母净利润为1.15/1.79/2.59亿元亿元，对应EPS分别为0.34/0.54/0.78元，当前股价对应PE分别为55.7/35.7/24.7x，考虑到公司超声骨刀业务处于快速放量阶段，国际化业务也已开始逐步突破，我们看好公司未来的发展前景，维持买入评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900027026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601696","688085"],"gpt_icon":0},{"id":"2607870744","title":"股市必读：三友医疗（688085）预计2025年全年营业收入5.35亿元至5.62亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607870744","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607870744?lang=zh_cn&edition=full","pubTime":"2026-01-29 02:42","pubTimestamp":1769625733,"startTime":"0","endTime":"0","summary":"截至2026年1月28日收盘，三友医疗报收于21.5元，下跌5.78%，换手率2.08%，成交量6.52万手，成交额1.43亿元。来自：三友医疗预计2025年全年归属净利润盈利5600万元至7280万元，同比增长显著。三友医疗发布业绩预告，预计2025年全年营业收入5.35亿元至5.62亿元。公司首次实施股权激励，确认股份支付费用约840万元，计提资产及信用减值损失约3,000万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900001522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688085"],"gpt_icon":0},{"id":"2606932793","title":"三友医疗(688085.SH)发预增，预计2025年归母净利润5600万元到7280万元，同比增加388.29%到534.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606932793","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606932793?lang=zh_cn&edition=full","pubTime":"2026-01-28 15:48","pubTimestamp":1769586493,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三友医疗(688085.SH)发布公告，公司预计2025年年度实现归属于上市公司股东的净利润为5600万元到7280万元，与上年同期(法定披露数据)相比，预计将增加4,453.14万元到6,133.14万元，同比增加388.29%到534.78%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398491.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"三友医疗(688085.SH)发预增，预计2025年归母净利润5600万元到7280万元，同比增加388.29%到534.78%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688085"],"gpt_icon":0},{"id":"2605422889","title":"1月23日三友医疗涨6.24%，融通健康产业灵活配置混合A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2605422889","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605422889?lang=zh_cn&edition=full","pubTime":"2026-01-23 15:36","pubTimestamp":1769153790,"startTime":"0","endTime":"0","summary":"证券之星消息，1月23日三友医疗涨6.24%，收盘报22.49元，换手率3.49%，成交量10.96万手，成交额2.41亿元。重仓三友医疗的公募基金请见下表：该股最近90天内共有6家机构给出评级，买入评级4家，增持评级2家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共6家，其中持有数量最多的公募基金为融通基金的融通健康产业灵活配置混合A/B。该公募基金现任基金经理为万民远。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300019760.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688085"],"gpt_icon":0},{"id":"2605042477","title":"三友医疗涨6.24%，中银证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2605042477","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605042477?lang=zh_cn&edition=full","pubTime":"2026-01-23 15:36","pubTimestamp":1769153783,"startTime":"0","endTime":"0","summary":"今日三友医疗涨6.24%，收盘报22.49元。2025年11月19日，中银证券研究员刘恩阳发布了对三友医疗的研报《国际化表现亮眼，国内业务逐步恢复》，该研报对三友医疗给出“买入”评级。研报中预计公司25-27年归母净利润为1.15/1.79/2.59亿元亿元，对应EPS分别为0.34/0.54/0.78元，当前股价对应PE分别为55.7/35.7/24.7x，考虑到公司超声骨刀业务处于快速放量阶段，国际化业务也已开始逐步突破，我们看好公司未来的发展前景，维持买入评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300019756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688085","601696"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774384340095,"stockEarnings":[{"period":"1week","weight":-0.0866},{"period":"1month","weight":-0.1748},{"period":"3month","weight":0.024},{"period":"6month","weight":-0.0797},{"period":"1year","weight":0.2386},{"period":"ytd","weight":0.0189}],"compareEarnings":[{"period":"1week","weight":-0.0416},{"period":"1month","weight":-0.0492},{"period":"3month","weight":-0.0151},{"period":"6month","weight":0.0073},{"period":"1year","weight":0.1517},{"period":"ytd","weight":-0.0221}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海三友医疗器械股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"9481人(较上一季度增加33.38%)","perCapita":"33618股","listingDate":"2020-04-09","address":"上海市嘉定区嘉定工业区汇荣路385号","registeredCapital":"33346万元","survey":"　　上海三友医疗器械股份有限公司的主营业务是医用骨科植入物和超声动力设备及耗材的研发、生产与销售。公司的主要产品是脊柱类和创伤类植入物、椎体成形类耗材、超声动力系统等。","listedPrice":20.96},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三友医疗(688085)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三友医疗(688085)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三友医疗,688085,三友医疗股票,三友医疗股票老虎,三友医疗股票老虎国际,三友医疗行情,三友医疗股票行情,三友医疗股价,三友医疗股市,三友医疗股票价格,三友医疗股票交易,三友医疗股票购买,三友医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三友医疗(688085)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三友医疗(688085)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}